Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

1.40
Delayed Data
As of Apr 29
 -0.11 / -7.28%
Today’s Change
1.28
Today|||52-Week Range
12.55
-56.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues194.0K391.0K291.0K863.0K
 
 
 
 
 
Depreciation And Amortization3.0K12.0K29.0K12.0K
 
 
 
 
 
 
Operating ExpensesGross Income191.0K------
 
 
General Expenses23.0M39.2M13.5M52.2M
 
 
 
 
 
Research And Development19.7M29.4M9.2M44.8M
 
 
 
 
 
Total Operating Expenses23.0M39.2M13.5M52.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.8M-38.9M-13.2M-51.4M
 
 
 
 
 
Extraordinary Credit0.000.0036.5M28.0M
 
 
 
Extraordinary Charge-23.2M-25.7M--0.00
 
 
 
Interest Expense On Debt793.0K1.6M1.0M678.0K
 
 
 
 
 
Other Expenses349.0K-661.0K384.0K-52.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-46.4M-66.8M22.6M-24.1M
 
 
 
 
 
Net Income-46.4M-66.8M22.6M-24.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS69.4M75.6M78.1M89.2M
 
 
 
 
 
Shares To Calculate EPS Diluted69.4M75.6M89.8M89.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.67-$0.88$0.25-$0.27
 
 
 
 
 
EPS Diluted-$0.67-$0.88$0.25-$0.27